Glanbia plc
Glanbia plc (GLAPY) Financial Performance & Income Statement Overview
Review Glanbia plc (GLAPY) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Glanbia plc (GLAPY) Income Statement & Financial Overview
Analyze Glanbia plc’s GLAPY earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q2 2024 | Q1 2024 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|
| Revenue | $847.43M | $841.26M | $1.27B | $1.28B |
| Cost of Revenue | $565.23M | $561.12M | $1.03B | $1.04B |
| Gross Profit | $282.20M | $280.14M | $240.46M | $241.91M |
| Gross Profit Ratio | $0.33 | $0.33 | $0.19 | $0.19 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $176.48M | $175.19M | $149.46M | $150.96M |
| Operating Expenses | $199.86M | $198.41M | $142.18M | $140.91M |
| Total Costs & Expenses | $765.10M | $759.52M | $1.17B | $1.18B |
| Interest Income | $0.00 | $0.00 | $2.34M | $2.35M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $29.87M | $29.65M | $29.23M | $29.41M |
| EBITDA | $117.43M | $116.58M | $101.90M | $102.52M |
| EBITDA Ratio | $0.14 | $0.14 | $0.08 | $0.08 |
| Operating Income | $82.33M | $81.73M | $98.28M | $72.51M |
| Operating Income Ratio | $0.10 | $0.10 | $0.08 | $0.06 |
| Other Income/Expenses (Net) | -$3.13M | -$3.10M | -$229100.00 | -$230475.00 |
| Income Before Tax | $79.21M | $78.63M | $98.05M | $98.64M |
| Income Before Tax Ratio | $0.09 | $0.09 | $0.08 | $0.08 |
| Income Tax Expense | $12.32M | $12.23M | $9.44M | $9.50M |
| Net Income | $66.89M | $66.40M | $88.71M | $89.24M |
| Net Income Ratio | $0.08 | $0.08 | $0.07 | $0.07 |
| EPS | $0.25 | $0.25 | $0.32 | $0.33 |
| Diluted EPS | $0.25 | $0.25 | $0.32 | $0.33 |
| Weighted Avg Shares Outstanding | $265.22M | $265.22M | $273.02M | $273.02M |
| Weighted Avg Shares Outstanding (Diluted) | $265.23M | $265.23M | $273.02M | $273.02M |
Over the past four quarters, Glanbia plc demonstrated steady revenue growth, increasing from $1.28B in Q1 2023 to $847.43M in Q2 2024. Operating income reached $82.33M in Q2 2024, maintaining a consistent 10% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $117.43M, reflecting operational efficiency. Net income rose to $66.89M, with EPS at $0.25. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan